China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Plant-Derived Recombinant Human Serum Albumin After Successful Reperfusion in Large-Core Acute Ischemic Stroke: The ALIVE Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132496
Registration Time: 2026/09/15
Type: Interventional study
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343359
Published by HT Digital Content Services with permission from Health Daily Digest....